Age-Related Macular Degeneration Market to Reach $18,500 Million by 2030, Says P&S Intelligence

13 Dec 2022
www.prnewswire.com
NEW YORK, Dec. 13, 2022 /PRNewswire/ -- According to the recent study published by P&S Intelligence, the size of the
age-related macular degeneration market was $10,234 million in 2021, and it will reach $18,500 million by 2030, at a growth rate of 6.8% in the years to come.
The development of the industry can be mainly credited to the snowballing cases of age-related eye ailments, the increasing elderly population, and the growing investments in research and development activities.
Eylea Sales Generate Most Revenue
Because of its protected patent and extensive market penetration, Eylea was the most-popular drug, with a revenue share of over 50%, in the past.
The requirement for Beovu will increase at the highest rate in the years to come, because of its higher drying efficiency, protection of its patent, and its accomplishment in treating severe cases of wet AMDAMD.
Get the sample pages of this report: https://www.psmarketresearch.com/market-analysis/age-related-macular-degeneration-market/report-sample
Wet AMD Holds Major Revenue Share
The wet AMDAMD category had the major revenue share in the past. This condition is managed with intravitreal injections, with over 22 million of these administered globally every year.
Additionally, over 75% of the anti-VEGF injections are administered for wet AMDAMD treatment. Furthermore, the availability of branded medications, high incidence of this condition, surge in the treatment count, and evolution in consciousness of this disease help in the growth of the industry.
The dry AMD category will record the higher growth rate in the years to come. This will be due to the projected introduction of numerous therapeutic candidates from 2023 onward and the increasing burden of this ailment, which accounts for over 85% of the AMDAMD cases.
Growing Elderly Population Responsible for Increasing Eye Disease
Cases
For older people, the loss of vision is a major issue, because it becomes worse with time. Both the dry and wet forms of macular degeneration can be fatal and need medical attention. Thus, the industry is expanding as a result of the increasing count of elderly patients.
Currently, only a few medications are licensed for treating this disease, generally anti-VEGFs. These medications require regular and painful intraocular injections, which leads to inconvenience and discourages people from going for the treatment. Hence, pharma companies are investing to develop long-acting anti-VEGFs and vitreous implants, to make treatment less daunting.
Browse detailed report on Age-Related Macular Degeneration Market Share, Growth and Demand Forecast to 2030
North America Is Largest Regional Market
North America had the largest revenue share, of about 51.1%, in the past, and it will sustain its dominance in the near future as well.
Some of the factors responsible for the growth of the market here are the mounting elderly population, the increasing incidence of this disease, the existence of major players, and the snowballing R&D activities.
Additionally, Europe follows North America because of the increasing customer preference for patented drugs and the large unmet AMDAMD treatment requirements in Europe. Moreover, the improvements in the lifestyle and the introduction of novel drugs will drive the market.
Global Age-Related Macular Degeneration Market Report Coverage
By Drug Type
Eylea
By Disease Type
Dry AMD
Wet AMD
By Age Group
Between 60 to 80
More Than 80
By Gender
Male
Female
By Stages
Early AMD
Intermediate AMD
Advanced AMD
No AMD
By Distribution Channel
North America
U.S.
Canada
Europe
U.K.
Germany
France
Spain
Italy
Asia-Pacific
China
India
Japan
South Korea
Australia
Latin America
Brazil
Mexico
Middle East and Africa
Saudi Arabia
South Africa
Browse More Reports Published by P&S
Global Wet Age-Related Macular Degeneration Market Size, Share, Growth, and Demand Forecast Report
Global Eye Testing Equipment Market Size, Share, Growth, and Demand Forecast to 2030
Global Intraoral Scanners Market Size, Share, Growth, and Demand Forecast to 2030
Global ENT Devices Market Size, Share, Growth, and Demand Forecast to 2030
Biologics CDMO Secondary Packaging Market Size, Share, Growth, and Demand Forecast to 2030
About
P&S Intelligence
P&S Intelligence provides market research and consulting services to a vast array of industries across the world. As an enterprising research and consulting company, P&S believes in providing thorough insights on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness. P&S keeps the interest of its clients at heart, which is why the insights we provide are both honest and accurate. Our long list of satisfied clients includes entry-level firms as well as multi-million-dollar businesses and government agencies.
Contact:
Prajneesh Kumar
P&S Intelligence
Phone: +1-347-960-6455
Email: [email protected]
Web: https://www.psmarketresearch.com
Follow Us: LinkedIn Twitter
Logo- https://mma.prnewswire.com/media/1224988/P_and_S_Intelligence_Logo.jpg
SOURCE P&S Intelligence
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
Drugs
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.